{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:ramipril",
  "owner": "cardio",
  "kind": "drug",
  "slug": "ramipril",
  "name": "Ramipril",
  "aliases": [
    "Altace"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Ramipril is an ACE inhibitor (angiotensin-converting enzyme inhibitor), a medicine taken by mouth. The US label read, for ramipril capsules (a generic product), lists three uses: treating high blood pressure, reducing the risk of heart attack (myocardial infarction), stroke or cardiovascular death in patients 55 years or older who are at high risk, and treating stable patients who show clinical signs of congestive heart failure after a myocardial infarction. The label read is a generic product label; the brand names for this substance are recorded as aliases.",
  "summary_technical": "RxNorm ingredient 35296; UNII L35JN3I7SJ. UNII L35JN3I7SJ is the UNII of the substance as the label names it. MeSH descriptor D017257 is Ramipril. Class: Angiotensin Converting Enzyme Inhibitor (FDA established pharmacologic class, RxClass). The label read is the Lupin Pharmaceuticals, Inc. label for ramipril capsules, application ANDA077626, effective 2026-08-24 in openFDA; Drugs@FDA lists the application's sponsor as LUPIN. The brand label for Altace (NDA019901, listed as discontinued in Drugs@FDA) and other generic ramipril labels were not used. This page records label indications and the class only: no trial result and no dose is given.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-09",
  "last_evidence_check": "2026-11-09",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "rxnorm",
      "value": "35296",
      "normalized_value": "35296",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "unii",
      "value": "L35JN3I7SJ",
      "normalized_value": "L35JN3I7SJ",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "mesh",
      "value": "D017257",
      "normalized_value": "D017257",
      "match": "exact",
      "version": "read 2026-11-09",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart",
        "blood-vessels"
      ],
      "condition-area": [
        "hypertension",
        "heart-failure",
        "coronary-and-vascular-disease"
      ]
    }
  },
  "payload": {
    "level": "substance",
    "mechanism": null
  },
  "content_digest": "4fb1c6ce9447bbdd019c85d09958e6144a3916bcdda695d580320c32966ae7f7",
  "review": {
    "content_digest": "4fb1c6ce9447bbdd019c85d09958e6144a3916bcdda695d580320c32966ae7f7",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-ramipril-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:ramipril",
      "category": "descriptive",
      "statement": "The US label of ramipril capsules, in the Lupin Pharmaceuticals, Inc. version dated 2026-08-24 in openFDA (a generic product), lists the medicine for the treatment of hypertension; in patients 55 years or older at high risk of developing a major cardiovascular event, to reduce the risk of heart attack (myocardial infarction), stroke or cardiovascular death; and in stable patients with clinical signs of congestive heart failure after a myocardial infarction.",
      "context": {
        "id": "cardio:ctx-fda-ramipril-label-us",
        "label": "Patients for whom the US label of ramipril capsules lists an indication: hypertension, cardiovascular risk reduction in patients 55 or older at high risk, heart failure after myocardial infarction",
        "recipient": "unknown",
        "population": "Patients described in the indications section of the label. The cardiovascular risk reduction indication names patients 55 years or older at high risk; the other indications do not state an age range.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "55 years or older for the risk reduction indication, as the passage read states; not stated for the other indications",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Patients with hypertension",
            "Patients 55 years or older at high risk of developing a major cardiovascular event",
            "Stable patients with clinical signs of congestive heart failure after myocardial infarction"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read, and the label has a boxed warning section whose content was not read or recorded. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE",
          "applicability_note": "The label sentences that give the indications named in the statement, each quoted in the research quote table.",
          "snapshot": {
            "id": "cardio:openfda-label-ramipril-lupin-2026-11-09",
            "retrieved_at": "2026-11-09T13:21:37Z",
            "content_hash": "24f903fd224e0ef770232bcf983d79d62f096b11a99cc6e76477543c06681017",
            "source_effective_date": "2026-08-24",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-ramipril-lupin",
            "source_type": "regulator",
            "title": "openFDA drug label record for ramipril capsules, Lupin Pharmaceuticals, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22a8cdec12-81d1-4ef4-82c0-d05d93c37a07%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id a8cdec12-81d1-4ef4-82c0-d05d93c37a07 (manufacturer Lupin Pharmaceuticals, Inc., application ANDA077626), returned on 2026-11-09. The label text is dated 2026-08-24 (effective_time). Other openFDA records of ramipril labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb22-openfda-label-ramipril-lupin.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20260824.",
          "snapshot": {
            "id": "cardio:openfda-label-ramipril-lupin-2026-11-09",
            "retrieved_at": "2026-11-09T13:21:37Z",
            "content_hash": "24f903fd224e0ef770232bcf983d79d62f096b11a99cc6e76477543c06681017",
            "source_effective_date": "2026-08-24",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-ramipril-lupin",
            "source_type": "regulator",
            "title": "openFDA drug label record for ramipril capsules, Lupin Pharmaceuticals, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22a8cdec12-81d1-4ef4-82c0-d05d93c37a07%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id a8cdec12-81d1-4ef4-82c0-d05d93c37a07 (manufacturer Lupin Pharmaceuticals, Inc., application ANDA077626), returned on 2026-11-09. The label text is dated 2026-08-24 (effective_time). Other openFDA records of ramipril labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb22-openfda-label-ramipril-lupin.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].products[0].brand_name",
          "applicability_note": "Drugs@FDA product listing for application ANDA077626, which confirms the product the label belongs to.",
          "snapshot": {
            "id": "cardio:drugsfda-anda077626-2026-11-09",
            "retrieved_at": "2026-11-09T13:21:39Z",
            "content_hash": "bf76a68dfcbe9d23ddaf931da089463694952084b2de52dda2c12a03a9db90a6",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:drugsfda-anda077626",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for application ANDA077626 (RAMIPRIL, sponsor LUPIN): product and sponsor",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22ANDA077626%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA, Drugs@FDA)",
            "edition": "The openFDA Drugs@FDA record for application ANDA077626, returned on 2026-11-09. It lists the sponsor and the products of the application; only the first product listing is quoted.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short values are quoted. The raw record is committed at research/snapshots/wb22-drugsfda-ramipril-lupin.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "40696419f7b648c339ca34d48ff00016e36f205bd42f6c884510c06f33b26842",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-ramipril-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "subtype_of",
        "label": "Ramipril is an ACE inhibitor (FDA established pharmacologic class in RxClass)",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ace-inhibitors",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-35296-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists hypertension as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-ramipril-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists clinical signs of congestive heart failure after a myocardial infarction in stable patients as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:heart-failure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-ramipril-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists reduction of the risk of myocardial infarction, stroke or cardiovascular death in people 55 or older at high risk as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:myocardial-infarction",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-ramipril-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists reduction of the risk of myocardial infarction, stroke or cardiovascular death in people 55 or older at high risk as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:stroke",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-ramipril-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01230034",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01230034-2010-10-28",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02499822",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02499822-2021-09-30",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02924727",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02924727-2023-06-22",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03715998",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03715998-2023-02-27",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05508035",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05508035-2026-07-31",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda019901",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda019901-2026-05-07",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda022021",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda022021-2012-01-18",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda219757",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda219757-2025-07-23",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/ramipril/",
  "context_path": "api/v1/context/cardio--ramipril.md"
}
